Is Invasive Micropapillary Serous Carcinoma a Low-grade Carcinoma?

被引:2
|
作者
Ohishi, Yoshihiro [1 ]
Imamura, Hiroko [1 ]
Aman, Murasaki [1 ]
Shida, Kaai [1 ]
Kaku, Tsunehisa [2 ]
Kato, Kiyoko [3 ]
Oda, Yoshinao [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka 8128582, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Fukuoka 8128582, Japan
[3] Kyushu Univ Hosp, Dept Obstet & Gynecol, Fukuoka 812, Japan
基金
日本学术振兴会;
关键词
Invasive micropapillary serous carcinoma; Low-grade and high-grade nuclear atypia; Mitotic activity; BRAF and TP53 gene mutation; MOLECULAR-GENETIC-ANALYSIS; OVARIAN-CARCINOMA; BORDERLINE TUMORS; CELL-TYPE; MUTATIONAL ANALYSIS; 2-TIER SYSTEM; PATTERNS; P53; POINT; KRAS;
D O I
10.1097/PGP.0000000000000211
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Invasive micropapillary serous carcinoma has been proposed as a synonym for low-grade serous carcinoma by some expert pathologists. In contrast, Singer and colleagues reported that some serous carcinomas with conspicuous invasive micropapillary pattern (SC-IMPs) can show high-grade nuclear atypia. However, the molecular features of such tumors have not been well documented. The aim of this study was to demonstrate and emphasize the fact that high-grade serous carcinoma confirmed by immunohistochemistry and molecular analysis can show conspicuous invasive micropapillary pattern. We selected 24 SC-IMPs and investigated: (1) their morphologic features; (2) the immunostaining pattern of p53 protein; and (3) KRAS/BRAF/TP53 gene mutations. The 24 SC-IMPs were subdivided into low-grade and high-grade tumors based primarily on the nuclear atypia, with the mitotic rate used as a secondary feature: low grade (n=5) and high grade (n=19). Low-grade SC-IMPs were characterized by low-mitotic activity, absence of abnormal mitosis, presence of serous borderline tumor, occasional BRAF mutation, and infrequent TP53 mutation. High-grade SC-IMPs were characterized by high-mitotic activity, presence of abnormal mitosis, conventional high-grade serous carcinoma, frequent TP53 mutation, and lack of KRAS/BRAF mutation. We demonstrated that high-grade serous carcinoma confirmed by aberrant p53 immunostaining and molecular analysis can show conspicuous invasive micropapillary pattern, validating Singer and colleague's report. Serous carcinoma with conspicuous invasive micropapillary pattern should not be readily regarded as low-grade serous carcinoma. Nuclear grade is the most important diagnostic feature in the SC-IMPs.
引用
收藏
页码:56 / 65
页数:10
相关论文
共 50 条
  • [21] The tuba origin of low-grade serous ovarian carcinoma
    Kong, Beihua
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 : S74 - S74
  • [22] Ovarian low-grade serous carcinoma: A comprehensive update
    Diaz-Padilla, Ivan
    Malpica, Anais L.
    Minig, Lucas
    Chiva, Luis M.
    Gershenson, David M.
    Gonzalez-Martin, Antonio
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 126 (02) : 279 - 285
  • [23] Advancements in Low-Grade Serous Carcinoma of the Ovary and Peritoneum
    Grisham, Rachel N.
    Chui, M. Herman
    [J]. CURRENT ONCOLOGY REPORTS, 2022, 24 (11) : 1549 - 1555
  • [24] Low-Grade Serous Ovarian Carcinoma: Challenges and Solutions
    Patni, Ranu
    [J]. INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2022, 20 (04)
  • [25] Estrogen signaling in low-grade serous ovarian carcinoma
    Tsang, Yvonne T. M.
    Ng, Chun Wai Oscar
    Gershenson, David
    Wong, K-Kwok
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [26] Immunosuppressive microenvironment in low-grade serous ovarian carcinoma
    Wong, Kwong-Kwok
    Gershenson, David M.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [27] Current concept of low-grade serous ovarian carcinoma
    Nakayama, Kentaro
    Razia, Sultana
    Ishibashi, Tomoka
    Kyo, Satoru
    [J]. TRANSLATIONAL CANCER RESEARCH, 2024, 13 (01) : 6 - 10
  • [28] The role of smoking in low-grade serous ovarian carcinoma
    Schlumbrecht, M.
    Sun, C.
    Wong, K.
    Broaddus, R.
    Gershenson, D.
    Bodurka, D.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S123 - S124
  • [29] Low-Grade Serous Carcinoma of the Ovary: The Current Status
    Babaier, Abdulaziz
    Mal, Hanan
    Alselwi, Waleed
    Ghatage, Prafull
    [J]. DIAGNOSTICS, 2022, 12 (02)
  • [30] Tubal origin of 'ovarian' low-grade serous carcinoma
    Li, Jie
    Abushahin, Nisreen
    Pang, Shujie
    Xiang, Li
    Chambers, Setsuko K.
    Fadare, Oluwole
    Kong, Beihua
    Zheng, Wenxin
    [J]. MODERN PATHOLOGY, 2011, 24 (11) : 1488 - 1499